A PCR-based method for manipulation of the vaccinia virus genome that eliminates the need for cloning.
A general method is described for altering specific genes of vaccinia virus (VV). We demonstrate and evaluate the procedure by gene inactivation, using a dominant selectable marker in conjunction with recombinant polymerase chain reaction (PCR). Primers based on the sequence of the target gene enable amplification of flanking arms and their subsequent attachment to the gpt cassette that confers resistance to mycophenolic acid. Linear PCR constructs are transfected into cells infected with wild-type vaccinia virus. Mutant viruses with gpt inserted into the target gene by homologous recombination are then selected by growth in the presence of MPA. This technique was applied to the vaccinia virus thymidine kinase gene and compared to the traditional method of constructing gpt-containing plasmids by cloning. The PCR scheme was found to be highly efficient and could theoretically be used to insert any foreign DNA element into any nonessential target gene for which partial or complete sequence information is available. The procedure can potentially be used for a wide variety of genetic modifications, including the insertion of foreign genes, with poxviruses and other DNA viruses. Genomes of microorganisms, such as bacteria and yeast that can be transformed with linear DNA, are also candidates for manipulation by this methodology.
Turner
P C
PC
Department of Immunology and Medical Microbiology, University of Florida, Gainesville 32610-0266.
Moyer
R W
RW
D001483:Base Sequence; D015139:Blotting, Southern; D003001:Cloning, Molecular; D004277:DNA, Single-Stranded; D005821:Genetic Techniques; D016679:Genome, Viral; D008969:Molecular Sequence Data; D009154:Mutation; D016133:Polymerase Chain Reaction; D013937:Thymidine Kinase / Q000235:genetics; D014162:Transfection; D014616:Vaccinia virus / Q000235:genetics*
D004277:DNA, Single-Stranded; D013937:Thymidine Kinase